Brain-specific drug delivery

Details Brain-specific drug delivery Brain-specific drug delivery

1984-10-29

1989-04-25

Gron, Teddy S.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514341, 514307, 514314, 514315, 544300, 544310, 546278, 546145, 546147, 546165, 546169, 546170, 546193, A61K 31515, A61K 3147, A61K 3144, A61K 3140

Patent

active

048248509

ABSTRACT:
The subject compounds, which are adapted for the site-specific/sustained delivery of centrally acting drug species to the brain, are:

REFERENCES:
patent: 2921072 (1960-01-01), Ferguson
patent: 3271399 (1966-09-01), Hitchings et al.
patent: 3892748 (1975-07-01), Hayao et al.
patent: 4006232 (1977-02-01), Hayao et al.
patent: 4479932 (1984-10-01), Bodor
patent: 4542141 (1985-09-01), Vandoni
CA 66:37835q, (1967).
CA 99:158321j, (1983).

Affiliated with

Also associated with

Rating

Brain-specific drug delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Brain-specific drug delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Brain-specific drug delivery will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1196029